Electrophysiology Instrument Allows Early Diagnosis of Glaucoma

A diagnostic device has been developed that will detect early cellular losses due to glaucoma and other ocular ailments.

Glaucoma is the world's major cause of vision loss. It occurs because of a buildup of fluid in the eyeball. After the fluid circulates, it empties through a drain in the front of the eye. In people with glaucoma, the drain in the eye is blocked and the fluid cannot run out of the eyeball. This caused increased pressure that destroys the nerve cells in the eye and leads to permanent vision loss.

The new diagnostic device is called the Claid-Perg and is a product of Paradigm Medical (Salt Lake City, UT, USA). "All research and studies indicate the Glaid-PERG diagnostic device is the earliest means of detecting cellular losses attributed to glaucoma and other ocular ailments,” said Paradigm Medical's CEO Raymond Cannefax. He added, "Early diagnosis will help reduce vision loss and help preserve sight.”

Paradigm Medical will introduce the Glaid-Perg together with the prototype version of its redesigned LD400 Autoperimetry system at the American Society for Cataract Refractive Surgeons (ASCRS) in April 2008, which will be held in Chicago (IL, USA) at the ASCRS show. The LD400 is used to measure patient visual fields to determine the severity of glaucoma and to aid in managing the disease.

The company signed an exclusive agreement with Lace Elettronica (Rome, Italy) to distribute the Glaid-Perg instrument.


Related Links:
Paradigm Medical
Lace Elettronica